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Background: Demyelinating plaques may induce headache through disruption of the pathways, which are implicated
in the pathogeneses of migraine. We report a case of 25-year-old female patient, who presented with status migrainosus
fulfilling the criteria of international classification of headache disorder. She was eventually diagnosed with
multiple sclerosis (MS) after an extensive work-up and long-term clinical and radiological follow-up.
Findings: At the onset of status migrainosus, magnetic resonance imaging (MRI) revealed the presence of several
demyelinating lesions fulfilling Swanton criteria. She was started on migraine prophylactic treatment but there
was no subsequent response. One year later, she presented with recurrent status migrainosus and a follow-up
MRI revealed multiple gadolinium-enhancing lesions in the brain. She was treated with abortive migraine medications.
Within the following 2 year, she developed ascending parasthesia and weakness of both lower limbs indicative of
incomplete transverse myelitis in association with recurrent status migrainosus. A diagnosis of MS was established
based on a follow-up MRI that satisfied the revised 2010 McDonald criteria. Both the headache and neurological
signs improved with IV methylprednisolone therapy. Her headache entered remission after initiation of a disease
modifying therapy.
Conclusion: Status migrainosus can be the initial presentation of MS. Unresponsiveness to migraine prophylactic
therapy in the presence of active demyelinating plaque in MRI brain may pose a diagnostic challenge and a diagnosis
of MS might be considered.
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Multiple sclerosis (MS) can cause various neurological
symptoms depending on the location of demyelinating
plaques (Putzki et al. 2009). Although the prevalence of
migraine is threefold higher in MS patients compared to
general population, headache is not typically considered
as one of the symptoms of MS (Kister et al. 2010a;
Noseworthy et al. 2000). Herein, we describe a young
female patient who presented with status migrainosus
as the initial presenting symptom of MS.* Correspondence: alroughani@gmail.com
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A 25-year-old female patient presented with severe, left
parieto-temporal throbbing headache associated with
nausea, vomiting and photophobia, which lasted for
7 days. Although she never had a previous history of
headache, she continued to have recurring migraine
headaches several times per week. Her headache fulfilled
the diagnostic criteria of international classification of
headache disorder, third edition (ICHD-3) (Headache
Classification Committee of the International Headache
S 2013). Her neurologic examination was unremarkable.
At the time of the initial presentation, unenhanced mag-
netic resonance imaging (MRI) brain showed subcortical
and periventricular T2/Flair hyperintense lesions, with
involvement of corpus callosum, left temporal lobe and
right middle cerebellar peduncle fulfilling Swanton Criteria
(Figure 1) (Swanton et al. 2006). She was diagnosed as mi-
graine with radiologically isolated syndrome (RIS). She was
started on topiramate as a prophylactic migraine therapy,s is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
Figure 1 Baseline axial and sagittal T2/flair MRI brain images (September 2011) showed demyelinating plaques involving the right
middle cerebellar peduncles (a), periventricular areas (b,c) and corpus callosum (d-f).
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She continued to use abortive medications (triptans &
non-steroidal anti-inflammatory drugs “NSAIDs”) till
her presentation with recurrent status migrainosus one
year later. A follow-up MRI revealed multiple new T2/
flair hyperintense lesions in the brain and spinal cord indi-
cative of radiological progression (Figure 2). A course of
propranolol was initiated as alternative prophylactic
migraine treatment but she continued to have recurrent
severe headaches. A follow-up MRI brain with gadolin-
ium, 6 months later, showed new T2/flair lesions in the
periventricular, corpus callosal and juxtacortical areas
along with new Gad-enhancing lesion at multiple supra-
tentorial sites (Figure 3).
Within one year, the patient presented with one-week
history of numbness and weakness of both lower legs
and urgency of micturition in association with an attack
of status migrainosus. Neurological examination showed
bilateral pyramidal weakness of lower limbs, pathological
brisk deep tendon reflexes and extensor plantars along
with loss of vibration and pinprick sensation up to thoracic
(T12) level. A follow-up MRI brain with gadolinium
revealed multiple new enhancing lesions with an open-ring
pattern (Figure 4). A lumbar puncture was performed andthe cerebrospinal fluid analysis revealed normal cell count,
protein, and glucose. Oligoclonal bands were positive in
the CSF and absent in the serum. Visual evoked potentials
revealed delayed P100 wave latencies in both eye. How-
ever, somatosensory and brainstem evoked potentials
were within normal limits. Autoimmune profile was
unremarkable.
The patient was diagnosed with MS according to the
revised 2010, McDonald criteria since she presented
with incomplete transverse myelitis and after MRI
showed dissemination in time and space (Polman et al.
2011). Her headache and neurological symptoms/signs
improved significantly after a 5-day course of intravenous
methylprednisolone. She was started on oral fingolimod
0.5 mg once daily as disease modifying therapy given her
reluctance to use any injectable forms of medications. The
headaches entered a remission phase for the next fol-
lowing months.
Discussion
Our case illustrates the association between the onset/ re-
currence of status migrainosus with progressive T2/flair
and new gadolinium enhancing demyelinating lesions on
the initial and subsequent MRIs (1.5 Tesla field strength).
Figure 2 Follow-up MRI brain images (October 2012) showed an increase in the lesion load on axial (a-c) and Sagittal (d-e) T2/flair
images when compared to the baseline MRI. Sagittal T2 spine images revealed a demyelinating plaque at C6 level (f).
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explain the presentation of MS onset with migraine head-
ache (Gee et al. 2005). Periaqueductal gray matter (PAG),
located in the midbrain, is thought to be a key area in the
pathogenesis of migraine. PAG acts as a rely station be-
tween cortical and brainstem structures and it modulates
pain by providing an antinociceptive effect to the primary
afferent system as well as influencing the autonomic and
behavioral responses (Raskin et al. 1987). PAG has con-
nections to the trigeminal nucleus caudalis (TNC), which
runs from the medulla down into the region of the third
cervical segment where it blends gradually into the
cervical dorsal horns. Some refer to this region as the
trigeminocervical complex (Ward 2012). Fibers from
upper cervical roots enter the TNC, which sends fibers
rostrally to the thalamus and collaterals to the autonomic
nuclei in the brainstem and the hypothalamus. Thalamic
neurons project to the somatosensory cortex but also to
areas of the limbic system (Goadsby et al. 2002). A prevail-
ing theory in the pathogenesis of the migraine attack is
that hyperexcitability develops along the trigeminovascu-
lar pathway, probably facilitated by a dysfunction of the
descending pain modulatory circuits (Raskin et al. 1987;
Ward 2012; Goadsby et al. 2002).The causal relationship between migraine and MS, in
our case, was suggested by the subsequent improvement
of headache with a DMT. On the other hand, a response
to corticosteroids such as methylprednisolone does not
necessarily this causal relationship as both conditions
may show improvement with the use of corticosteroids.
Both migraine and MS are relatively common in young
females and both may accidentally co-exist. The preva-
lence of migraine in patients with MS is between 20% to
45% (Kister et al. 2010b). The diagnosis of migraine
precedes MS in most cases (Kister et al. 2010a; Fragoso
& Brooks 2007; Yetimalar et al. 2008; Villani et al. 2008)
and it is suggested to be a presenting symptom of MS
(Kister et al. 2012; Zorzon et al. 2003; Lin et al. 2013).
Freedman et al. reported migraine headache at MS onset
in 18 (1.6%) out of 1113 patients with MS and an
additional 26 (2.3%) patients experiencing recurrent
headaches at the time of MS exacerbation, often accom-
panied by posterior fossa signs (Freedman & Gray 1989).
Migraine and MS share several features. Both have a
relapsing-remitting course affecting the central nervous
system with occasional chronic evolution, more prevalent
in women of childbearing age, and both appear to be
influenced by hormonal changes; i.e., less exacerbations
Figure 4 Follow-up MRI brain scans (March 2014) showed a significant increase in the lesion load involving the periaqueductal gray
matter (a), periventricular and juxtacortical regions (b,c), corpus callosum, extending lesions to cortical areas (d,e) in both axial and
sagittal T2/flair scans. Enhanced axial T1 MRI scans showed the presence of new gadolinium-enhancing lesions in the temporal, frontal and
parietal lobes (f-h).
Figure 3 Follow-up MRI brain scans (April 2013) showed new T2/flair lesions in periventricular and juxtacortical regions with an
increase in the overall lesion load when compared to the previous MRI scan as seen in the axial (a-c) and sagittal images (d-e).
Enhanced Axial T1 MRI images showed five gadolinium-enhancing supratentorial lesions involving both hemispheres (f-h).
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et al. 2010b).
The mechanism behind the association of MS and
migraine is debatable and several hypotheses were intro-
duced. First, headache may be induced by the inflamma-
tory demyelinating MS lesions by disrupting the pathways
implicated in the pathogenesis of migraine (Kister et al.
2010b). It was observed that lesions within the midbrain
especially in the PAG were commonly associated with
comorbid migraine in MS patients (Gee et al. 2005;
Tortorella et al. 2006). It should be noted that the inflam-
matory process caused by demyelination is not necessarily
the cause of headaches given the incidental co-existence
of both conditions. Second, a dysregulation of the seroto-
ninergic system caused by demyelinating lesions has been
linked to the headache exacerbation (Sandyk & Awerbuch
1994). Third, cortical demyelination has been shown to
accelerate cortical spreading depression, which is a key
mechanism in migraine pathophysiology (Merkler et al.
2009). Although cortical demyelinating plaques were seen
in our case (Figure 4d,e), it is often difficult to detect
definitive cortical involvement given the low sensitivity of
conventional MRI. Finally, it is suggested that migraine
with aura may be associated with MS activity since the
development of aura involves activation of matrix meta-
lloproteins resulting in subtle increase in permeability of
the blood–brain barrier and thus presumptive neuro-
inflammation (Gursoy-Ozdemir et al. 2004). Kistar et al.
proposed that certain privileged central nervous system
compartment to circulating Tcells may be sensitized during
migraine aura (Kister et al. 2010b).Conclusion
Status migrainosus in the presence of demyelinating
MRI features at the initial presentation may pose diag-
nostic dilemma. Failure to respond to prophylactic mi-
graine therapy in view of progressive demyelinating
features on follow-up MRIs may point to another rela-
tively common neurological disorder such as MS among
young women.Consent
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